Skip to main content
. 2022 Oct 28;23:937. doi: 10.1186/s12891-022-05900-x

Table 1.

Baseline characteristics, N = 122, n (%) unless otherwise specified

Overall
(wgt. N = 122.0)
n (%) or mean (SD)
Statin Users
(wgt. N = 9.4a)
n (%) or mean (SD)
Statin Non-users
(wgt. N = 112.6)
n (%) or mean (SD)
p-value**
Age, mean (SD) 55.5 (9.1) 61.7 (8.9) 55.0 (9.0) 0.031
Female 68.0 (55.7) 3.8 (40.9) 64.2 (57.0) 0.340
BMI, mean (SD) 26.1 (4.0) 29.5 (4.2) 25.8 (3.9) 0.007
Hypertension 18.9 (15.5) 2.6 (27.5) 16.4 (14.5) 0.293
Dyslipidemia 15.9 (13.1) 6.2 (66.1) 9.7 (8.7) < 0.001
Cardio/cerebrovascular disease 5.0 (4.1) 1.9 (20.5) 3.1 (2.8) 0.009
Diabetes Mellitus 10.4 (8.5) 3.6 (38.9) 6.8 (6.0) < 0.001
KL grade < 0.001
 0 49.7 (40.8) 0.8 (8.1) 49.0 (43.5)
 1 24.0 (19.7) 1.1 (11.3) 23.0 (20.4)
 2 27.4 (22.5) 0.9 (9.2) 26.6 (23.6)
 3 13.8 (11.3) 4.7 (49.6) 9.1 (8.1)
 4 7.1 (5.8) 2.0 (21.8) 5.0 (4.5)
WOMAC pain, mean (SD) 19.1 (17.3) 24.7 (21.2) 18.6 (17.0) 0.304
WOMAC function, mean (SD) 16.8 (17.3) 25.5 (17.5) 16.1 (17.2) 0.111
WOMAC stiffness, mean (SD) 23.3 (23.0) 45.7 (29.6) 21.4 (21.3) 0.002
Max cartilage damage score 0.209
 0/1 18.4 (15.1) 0.0 (0.0) 18.4 (16.4)
 2 34.2 (28.0) 1.8 (19.4) 32.4 (28.7)
 3 39.5 (32.4) 2.9 (30.5) 36.7 (32.6)
 4 29.9 (24.5) 4.7 (50.1) 25.2 (22.4)
Max osteophytes score 0.093
 0 6.8 (5.6) 0.0 (0.0) 6.8 (6.1)
 1 52.5 (43.0) 1.8 (19.4) 50.6 (45.0)
 2 49.3 (40.4) 4.5 (47.8) 44.8 (39.8)
 3 13.4 (11.0) 3.1 (32.8) 10.3 (9.2)
Max BML score 0.758
 0 53.3 (43.7) 2.8 (30.4) 50.5 (44.8)
 1 26.6 (21.8) 1.8 (19.5) 24.8 (22.0)
 2 29.5 (24.2) 3.2 (33.9) 26.3 (23.4)
 3 12.5 (10.3) 1.5 (16.2) 11.0 (9.8)
MRI effusion 0.905
 0 31.3 (25.6) 1.7 (17.7) 29.6 (26.3)
 1 54.6 (44.8) 5.1 (54.7) 49.5 (43.9)
 2 30.9 (25.3) 2.1 (22.0) 28.8 (25.6)
 3 5.2 (4.3) 0.5 (5.6) 4.7 (4.2)

aOur analysis is population weighted using decade-gender stratum sampling weights, and the reported numbers are weighted numbers

** Chi-square test for categorical/binary variables, or t-test for continuous variables